NCT07398742

Brief Summary

Importance: After a primary total knee arthroplasty (TKA), we anticipate that obese individuals are more likely to experience a of periprosthetic joint infection (PJI). Knowing the microbial profile in obese patients can potentially help in choosing the proper prophylactic measures for this group as well as tailoring the empirical antibiotics in relation to PJI in obese patients. Objective: To compare incidence of PJI revisions within 2 years after TKA in obese vs non-obese OA patients. Secondarily: To compare microbial profiles of infections in these groups in two time windows: early (≤90 days) vs late (91-730 days) and incidence of revisions due to all causes within 2 years.Design and Setting: We will include patients having primary knee arthroplasty using Danish national registers. Patients will be stratified into anthropometric groups, referred to as exposed and unexposed to obesity, based on their baseline Body Mass Index (BMI). Participants included in the analysis population will be followed up for 2 years, until first revision, death or migration whichever comes first. Participants: We will include adult patients with available weight and height data with primary/idiopathic or secondary (due to meniscus or cruciate ligament lesion) OA who received primary TKA in the period from 2011-01-01 and 2021-02-28. Patients will be identified from the Danish knee arthroplasty register. Exposure and Comparator: The cohort will be divided into obese (exposed), defined as body mass index (BMI) ≥ 30 kg/m2; and non-obese (unexposed), defined as BMI \< 30 kg/m2. Main Outcomes and Measures: The primary outcome will be revision due to prosthetic joint infection (PJI) within 730 days following TKA. Secondary endpoints will then be to examine revision due to all causes within 730 days following TKA and type of microbial infection between obese and non-obese in the first 90 days and the period from 91 days to 730 days following TKA. Planned Statistical Analyses: We will use descriptive statistics to summarize the baseline characteristics of the two groups. Hazard ratios with corresponding two-sided 95% confidence intervals (95%CIs) for experiencing the outcome will be estimated using a Cox proportional hazards regression model. We will fit both unadjusted (crude) model and a propensity score adjusted model calculated based on age, sex, highest completed education, household income, comedications, and Elixhauser Comorbidity Measure (ECM), all collected up to the day of surgery. Stratified analyses will categorize PJI cases by bacterial infection and compare crude proportions between groups based on the absolute risk difference with 95% confidence intervals. Ethical Considerations and Registration: The study and its statistical analysis plan will be registered in clinicaltrials.org prior to conducting the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101,299

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 10, 2026

Completed
Last Updated

February 10, 2026

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

September 25, 2025

Last Update Submit

February 2, 2026

Conditions

Keywords

microbiological profilesknee arthroplastyobesitypji

Outcome Measures

Primary Outcomes (1)

  • Incidence Periprosthetic joint infection

    PJI: our definition of PJI is adapted from The European Bone and Joint Infection Society (EBJIS) criteria as at least one of the following: A. Danish Knee Arthroplasty Register-registered revision surgery due to infection. B. At least 2 deep-tissue samples of phenotypically indistinguishable bacteria isolated from at least 3 deep-tissue samples C. One or more positive intraoperative samples from a closed fluid aspirate AND a biopsy (fluid AND tissue) of phenotypically indistinguishable bacteria isolated.

    2 years

Secondary Outcomes (3)

  • Incidence of Revision due to all causes

    2 years

  • Proportions Microbiological profiles in periprosthetic infection

    90 days

  • Proportions of Microbiological profiles in periprosthetic infection

    91 days to 2 years

Study Arms (2)

Patients with obesity

Patients with body mass index of 30 or more

Patients without obesity

Patients with body mass index less than 30

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In order to be eligible, we will include adult patients with primary or secondary osteoarthritis (due to meniscus or cruciate ligament lesion) who underwent primary TKA between January 1, 2011, and February 28, 2021, and for whom weight and height data are available. Patients will be identified from the DKR. Patients are followed for 2 years, until first revision, death or migration, whichever comes first.

You may qualify if:

  • Adults with available BMI data recieved knee arthroplasty due to osteoarthritis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopedic surgery and traumatology, Bispebjerg Hospital, Copenhagen, Denmark

Copenhagen NV, 2400, Denmark

Location

MeSH Terms

Conditions

ObesityJuvenile polyposis syndrome

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Phd. student

Study Record Dates

First Submitted

September 25, 2025

First Posted

February 10, 2026

Study Start

January 1, 2025

Primary Completion

November 25, 2025

Study Completion

November 25, 2025

Last Updated

February 10, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations